At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Samplingsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Study Aiming to Determine the Cartography of Virological Reservoir Related to Antiretroviral Concentrations in Chronic HIV-1 Patients Treated With a First Line of Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs).
In Brief
A clinical study evaluating Samplings for HIV-1 Infection. Completed, enrolled 20 participants across 8 sites.
Detailed Summary
The main objective of the study is to characterize the diffusion of dolutegravir and associated backbone (abacavir/lamivudine or tenofovir/emtricitabine) in HIV-1 chronic patients in the main putative reservoirs, namely inguinal lymph nodes, rectal, fat tissues and sperm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV-1 Infection
CountriesFrance
CollaboratorsViiV Healthcare
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartFeb 2020
Primary CompletionJun 2023
TodayJul 2026
First PostedOct 21, 2019
Enrollment StartFeb 10, 2020
Primary CompletionJun 9, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.7 years ago
Interventions
Samplingsother
* blood samples * rectal biopsies * nodes biopsies * cutaneous fat tissues biopsies * semen sample